前列腺癌患者的尿道外前列腺手术:基于人群的并发症和死亡率的比较分析
Michele Marchioni1,2, Giulia Primiceri2, Alessandro Veccia3
1Laboratory of Biostatistics, Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti, Chieti, Italy.
Asian journal of urology
|February 5, 2024
概括
经过尿道式前列腺手术的前列腺癌 (PCa) 患者与良性前列腺激增症 (BPH) 患者相比,并发症和死亡率相似. 诊断似乎不会影响手术结果或技术的有效性.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 手术瘤学手术瘤学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 下泌尿道症状 (LUTS) 在前列腺癌 (PCa) 和良性前列腺增生 (BPH) 两种情况下都很常见.
- 一些PCa患者可能被错误诊断和治疗BPH,影响手术结果.
- 了解PCa与BPH对跨尿道前列腺手术结果的影响对于患者管理至关重要.
研究的目的:
- 为了比较PCa和BPH患者进行过尿道式前列腺手术的外科结果.
- 评估PCa与BPH对并发症和死亡率的影响.
- 评估PCa诊断是否会影响不同外科手术技术的结果.
主要方法:
- 来自美国外科医生学院国家外科质量改善计划数据库 (2011-2016) 的34,542名患者的回顾性分析.
- 患者根据术后诊断进行了分层:PCa (2008) 与BPH.
- 后勤回归模型分析了术后发病率和死亡率的预测因素,并进行了诊断和手术技术的相互作用测试.
主要成果:
- 在PCa和BPH患者之间的术后并发症没有统计学上显著的差异 (OR 0.9,95% CI 0.7-1.1;p=0.252).
- 观察到类似的术后死亡率,心血管事件,输血和长时间住院.
- 在PCa诊断和手术技术结果之间没有发现显著的相互作用.
结论:
- 与BPH相比,PCa诊断不会导致经尿道前列腺手术后的术后发病率或死亡率增加.
- 手术技术的结果并没有受到PCa诊断的显著影响.
- 目前通过尿道进行的前列腺手术方法似乎对PCa和BPH患者都是安全有效的.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
188
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
188
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348


